Methods: MICs were determined by BSAC agar dilution methodology and isolates exhibiting resistance to one or more carbapenems were screened for carbapenemase genes by PCR. Plasmid analyses were performed after electro-transformation of carbapenemase-encoding plasmids. WGS was performed on both transformants and clinical isolates. Patient data provided by the sending laboratories were reviewed.
Introduction
Carbapenem-resistant Enterobacteriaceae are considered by the WHO to be a critical public health issue of global concern that requires immediate action. 1 Carbapenem antibiotics are a last-resort treatment for MDR bacterial infections and so the emergence of resistance is particularly worrying. Resistance to carbapenems can be caused by several mechanisms, including permeability changes, or AmpC/ESBL acquisition/overexpression and efflux, 2 but of greatest concern is the acquisition of carbapenemases. Carbapenemase-producing Enterobacteriaceae (CPE) are reported globally with increasing frequency and with numerous reported outbreaks, and some countries reporting nationwide endemicity. [3] [4] [5] Globally, five carbapenemase families dominate in Enterobacteriaceae, and these are members of three Ambler classes: KPC (class A); IMP, NDM and VIM (class B); and OXA-48-like (class D). 4 Carbapenemase genes are encoded on mobile genetic elements and their dissemination has been associated with both successful high-risk clones (e.g. KPC in Klebsiella pneumoniae clonal group ST258) 6 and interand intra-species plasmid spread (e.g. bla KPC in pKpQIL and bla OXA-48-like in pOXA-48a). 7 CPE are frequently MDR since carbapenemase plasmids often harbour genes that encode resistance to other antibiotic classes (e.g. qnrB1 encoding decreased susceptibility to quinolones in pNDM-MAR), 8 and/or additional resistance genes may be encoded on other plasmids or on the chromosome, resulting in severely limited treatment options. Consequently infection with CPE is associated with prolonged hospital stays and increased mortality. epidemiology of CPE within this region over a 7 year period between 2007 and 2014.
Materials and methods

Bacterial isolates, identification and susceptibility testing
Isolates were submitted to PHE's Antimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit from laboratories in the West Midlands between November 2007 and December 2014 for investigation of 'unusual' resistance, including to carbapenems. They were identified using chromogenic agars [CHROMagar TM Orientation (CHROMagar, Paris, France) and Brilliance UTI (Oxoid, Basingstoke, UK)], API-20E tests (bioMérieux SA, Marcy-l' Etoile, France) or, since August 2012, by MALDI-TOF MS (Bruker Microflex LT, Bruker Daltonik GmbH, Bremen, Germany).
MICs were determined by BSAC agar dilution 11 using AMRHAI's standard Gram-negative antibiotic panel, which includes ertapenem, meropenem and imipenem (with/without 320 mg/L EDTA to detect metallocarbapenemase producers) and interpreted using EUCAST breakpoints. 12 
Screening for carbapenemase genes
Isolates exhibiting resistance, based on EUCAST clinical breakpoints, to one or more of ertapenem, imipenem and meropenem were screened by inhouse PCRs for the presence of KPC, OXA-48-like, IMI, NDM, IMP, VIM, GIM, SIM and SPM carbapenemase genes. 13, 14 Rarer carbapenemase genes were also sought by analysis of WGS data.
Plasmid transformation
Transformation of KPC, NDM and VIM carbapenemase-encoding plasmids was attempted by electroporation using Escherichia coli Alpha-Select recipient cells (Bioline, London, UK). Transformants were selected on LB agar containing 100 mg/L ampicillin and a 10 lg ertapenem disc (Oxoid Ltd, Basingstoke, UK) and were screened for carbapenemase genes by in-house PCR assays.
WGS and analyses
WGS was performed on 139 clinical isolates and 96 transformants. Genomes were sequenced using the Nextera sample preparation method and standard 2 % 150 base sequencing protocols on a HiSeq instrument (Illumina, San Diego, CA, USA). Low-quality nucleotides were removed using Trimmomatic as previously described. 15 Reads were assembled into contigs using SPAdes 3.5.0 (http://bioinf.spbau.ru/spades), with K-mer values of 21, 33, 55 and 77. STs, the presence of resistance genes and plasmid replicon types were determined using MLST 1.8, ResFinder 2.1 16 and PlasmidFinder 17 on the Center for Genomic Research platform (https://cge. cbs.dtu.dk/services/).
Contigs from transformant and clinical isolates carrying carbapenemases were compared with the GenBank nucleotide database using BLAST to identify their closest plasmid or mobile genetic element (MGE) matches and to compose a list of known plasmid sequences to be used as references. Reads and assembled contigs were concurrently mapped to reference sequences obtained from GenBank using an in-house algorithm and progressive Mauve alignment software. 18 A 75% coverage and identity criterion was applied to assess relevant matches (Table S1 , available as Supplementary data at JAC Online).
Patient demographic information
Patient data were obtained from the accompanying request forms sent with submissions from referring laboratories.
Data analysis
Data were analysed using Microsoft Excel software.
Results and discussion
Demographics of patients affected and distribution
All carbapenemase-positive Enterobacteriaceae isolates received by PHE's AMRHAI Reference Unit from the West Midlands from November 2007 to December 2014 were reviewed. Isolates were submitted from 22 hospital laboratories and 139 carbapenemasepositive isolates, obtained from 59% (13/22) of submitters (Table 1) , were confirmed. These were from 108 patients except one isolate, which was obtained from an endoscope camera head in a urology theatre. Most source patients were hospitalized (78%; 84/108), but a few were outpatients (8%; 9/108) or in primary care (13%; 14/108) and one was in an unknown setting. The mean patient age was 63.9 years and patients were predominantly male (64%; 69/108).
Foreign travel history was available for 42/108 (39%) patients. Of these, 23 had documented travel within the previous 6 months: 14/23 to India, 5/23 to Pakistan, and single patients to Egypt, Greece, Spain and Turkey. Of the 14 patients who had travelled to India, 10 yielded isolates that were NDM-positive, two patients had OXA-48-like-positive isolates and two patients carried distinct isolates that were positive for both NDM and OXA-48-like genes. All five patients with recent travel to Pakistan carried isolates that were NDM-positive. Despite the fact that we cannot definitively ascertain where the NDM-positive isolates were acquired, this finding is consistent with the hypothesis that travel to the Indian subcontinent may be acting as a means by which NDM-producing isolates can be transported into the UK, as has been previously postulated. 19 Single carbapenemase-producing isolates were referred from 85/108 (79%) patients and multiple isolates were referred from the remaining 23/108 (21%). Amongst the 23 patients from which multiple isolates were obtained, seven yielded isolates of different species or genera with carbapenemase genes. Two patients each had two KPC-positive isolates of different species (one had a K. pneumoniae and an Enterobacter cloacae complex; the other an E. coli and an E. cloacae complex). Three patients had multiple NDM-positive isolates (two with a K. pneumoniae and an E. cloacae complex, and one with a K. pneumoniae and an E. coli). The last two patients yielded isolates that produced NDM and OXA-48-like enzymes [one with E. coli (OXA-48-like) and Morganella morganii (NDM); and one with K. pneumoniae (OXA-48-like) and E. coli (NDM)]. The remaining nine patients had multiple isolates of the same species and harboured the same carbapenemase alleles.
Microbiology
The majority of confirmed CPE isolates were K. pneumoniae (64%; 89/139), followed by E. coli (18%; 25/139), E. cloacae complex (15%; 21/139), Providencia rettgeri (1%; 2/139) and one isolate each of Citrobacter freundii and M. morganii.
If patient samples, rather than patients, were considered as the denominator, most specimens were taken in hospitals (87%; 121/138), although some (12%; 17/138) were general practice urines. Overall, the most frequently reported specimen type Carbapenemases in the West Midlands JAC was urine (45%; 62/138), followed by faeces (24%; 33/138). Eight percent of samples (11/138) were obtained from tissue and fluid samples, 7% (10/138) from blood cultures or line tips, 6% (8/138) from respiratory samples, 5% (7/138) from undefined 'screening swabs', and 5% (7/138) were unknown specimen types.
Carbapenemase alleles, typing of the isolates and plasmid analyses
All 139 isolates had their carbapenemase alleles defined and were typed by inferring MLST profiles from WGS data where an MLST scheme exists. After the exclusion of isolates of the same species exhibiting the same ST from single patients and harbouring the same carbapenemase, 119 isolates remained for analysis, comprising: 73 K. pneumoniae, 23 E. coli, 19 E. cloacae complex, 2 P. rettgeri and 1 each of C. freundii and M. morganii (Table 2) . Transformants were obtained for 95/119 (80%) isolates (94 transformants from single carbapenemase-producing isolates and 2 transformants from an isolate producing two carbapenemases). Where transformants were not obtained, clinical isolate WGS data were analysed for the presence of reference plasmid sequences. bla NDM was the most prevalent carbapenemase detected, representing 69/119 (58%) of all carbapenemase-positive isolates. This was followed by bla KPC (26/119; 22%), bla OXA-48-like (16/119; 13%), bla VIM (7/119; 6%) and one isolate that had both bla NDM and bla OXA-48-like genes.
KPC (n " 26)
KPC-positive isolates comprised E. cloacae complex (n " 11), K. pneumoniae (n " 11) and E. coli (n " 4) ( Table 2 ). bla KPC-2 was the dominant variant, present in 23/26 (88%) isolates and bla was found in the remaining three. Within E. cloacae complex isolates five STs were found; four were represented by single isolates, but ST133 had seven representatives, submitted by three laboratories over a 27 month period. The four KPC-positive E. coli isolates represented four unrelated STs. Of the 11 KPC-positive K. pneumoniae isolates, five belonged to clonal group (CG) 258 (four ST258 and one ST512) and were submitted from three laboratories over a 50 month period; the remaining six isolates represented four unrelated STs. CG258 have previously been reported to be the dominant hosts of KPC genes in the UK 20 as well as in several other countries globally. [21] [22] [23] Transformants were obtained for 24/26 (92%) KPC-positive isolates. Four different plasmid replicon types were identified: IncN (18/24), IncF (3/24), IncA/C (2/24) and IncI2 (1/26). IncN was the dominant plasmid replicon type in all three species of KPC-positive isolates and was found to represent a bla KPC-2 -encoding plasmid structure, which we have designated pKPC-IncN1, in 14/18 isolates submitted from four laboratories. pKPC-IncN1 was 61 kb and additionally encoded bla TEM-1 , strA, strB, dfrA18 and sul1 genes. BLAST and mapping analyses revealed that the 14 pKPC-IncN1 sequences shared 78%-87% similarity to another bla KPC-2 -encoding plasmid, pCF8698 (GenBank accession number LN610760). This plasmid backbone was found among several species and STs from multiple submitting laboratories, indicating that inter-and intraspecies plasmid spread may play a significant role within KPC carbapenemases in the West Midlands; it is also suggestive of a plasmid-mediated outbreak.
Three IncF plasmids, found in K. pneumoniae and E. cloacae complex isolates, exhibited .99% identity to pKpQIL (GenBank accession number NC_014016), 24 as did WGS reads from the two clinical isolates for which no transformants were generated. Several other antibiotic resistance genes were additionally encoded by KPC plasmids, as listed in Table 2 .
OXA-48-like (n " 16)
OXA-48-like-positive isolates comprised K. pneumoniae (n " 11), E. coli (n " 4) and C. freundii (n " 1) ( Table 2) . bla OXA-48 was the most common variant, representing 6/16 isolates obtained from four submitting laboratories, followed by bla OXA-181 (4/16) and bla OXA-232 (4/16) each from three laboratories, and one each of bla OXA-244 and bla OXA-245 . Within the 16 isolates at least nine different STs were found across the three species. Analysis of clinical isolate sequencing data revealed that five bla OXA-48-like plasmids were IncL/M, four had a ColE-like replicon (ColKP3), one had an IncA/C replicon and the last plasmid had an IncHI1 replicon. The five IncL/M plasmids exhibited .99% identity to pOXA-48a, 7 although it is important to note that one of these plasmids carried bla , and the four ColE-like plasmids exhibited .99% identity to pOXA-232 25 (GenBank accession numbers NC_019154 and JX423831). A plasmid or chromosomal location could not be established for the bla OXA-48-like alleles in two of the remaining five isolates, but contigs from three E. coli isolates exhibited .99% 
Findlay et al. Carbapenemases in the West Midlands JAC (two isolates, both ST38) and 89% (one isolate, ST69) identity to a 90.6 kb chromosomal DNA sequence and all three exhibited 100% identity to a chromosomally inserted 9.7 kb plasmid fragment (GenBank accession number KT444704) that has been previously described in E. coli ST38 isolates, 26 indicating that their carbapenemases were likely to be chromosomally encoded. This has been previously reported for members of ST38, 26 but, as evidenced here, can also be found in other STs. None of the analysed OXA-48-like plasmids encoded any additional resistance genes. Half of the OXA-48-like plasmids were identified as either pOXA-48a (4/8) or pOXA-232 (4/8), both of which have been found globally. 7 One K. pneumoniae isolate was also shown to carry a plasmid with .99% similarity to pOXA-48a, but carrying the OXA-245 variant, perhaps indicating the stability of this plasmid structure with other OXA-48-like variants. Although previously reported as an IncL/M plasmid, pOXA-48a has subsequently been redefined in a recent publication as an IncL plasmid. 27 
NDM (n " 69)
NDM-positive isolates comprised K. pneumoniae (n " 43), E. coli (n " 15), E. cloacae complex (n " 8), P. rettgeri (n " 2) and M. morganii (n " 1) ( Table 2 ). bla NDM-1 was the most common allele, (60/69) followed by bla NDM-5 (6/69), bla NDM-7 (2/69) and bla NDM-4 (1/69). All NDM-positive K. pneumoniae, E. cloacae complex and P. rettgeri isolates harboured only the variant NDM-1, whilst some NDM-positive E. coli and M. morganii isolates harboured NDM-1 as well as other NDM variants, i.e. NDM-4, NDM-5 and NDM-7. Within K. pneumoniae, 14 STs were identified, 13 of which were represented by no more than 3 isolates; however, 22 isolates were ST231. These 22 isolates were referred from five laboratories over a period of 52 months.
Transformants were obtained from 41/43 NDM-positive K. pneumoniae isolates. Analysis of the bla NDM plasmids in the 22 ST231 isolates identified that 13 of the plasmids were IncA/C, 8 were IncF and 1 was IncF/IncR. The 13 ST231 isolates with IncA/C plasmids were previously implicated in an outbreak in a single hospital in which the K. pneumoniae strain was found on the endoscopic camera head (one isolate) in a urology theatre and subsequently was isolated from the urine of 12 patients. 28 Analyses of plasmid sequences revealed that the plasmids from all 13 isolates involved in this outbreak showed .99% identity to a 137 kb plasmid, pKP1-NDM-1 (GenBank accession number NC_023908), reported from Australia in 2014. 29 Over half (22/43) of K. pneumoniae isolates harboured plasmids with IncF replicons; however, these replicons were found associated with a diverse range of plasmids ranging in size from 83 to 273 kb. Two IncF plasmids exhibited .99% identity to the plasmid pNDM-MAR 8 (NC_016980), three had .99% identity to blaNDM-1-plasmid2 30 (NZ_CP009115) and four had .99% identity to pMC-NDM 31 (NC_025106).
Eleven STs were identified amongst the 15 NDM-positive E. coli isolates and transformants were obtained for 13 of these. Four different replicon types were found: IncA/C (5/13), IncX3 (4/13), IncF (3/13) and a single plasmid with IncHI2. All five IncA/C plasmids showed .99% identity to pKP1-NDM-1, whilst the four IncX3 plasmids exhibited .99% identity to pNDM-MGR-K194 (NC_022740) from India. 32 The five pKP1-NDM-1-like plasmids were in E. coli isolates submitted from five hospitals, none of which was the hospital with the aforementioned K. pneumoniae pKP1-NDM-1 outbreak. Five STs were identified within the eight NDM-positive E. cloacae complex isolates and transformants were obtained for all of these. Three plasmid replicon types were identified: IncF (5/8), IncA/C (2/8) and IncX3 (1/8). Both IncA/C plasmids exhibited .99% identity to pKP1-NDM-1 and three IncF plasmids exhibited .99% identity to pMC-NDM. Both pKP1-NDM-1-like plasmids were from different hospitals and not associated with the previous K. pneumoniae outbreak. The M. morganii harboured bla NDM-5 on a ColElike plasmid, for which no similar sequence was found in GenBank, and no transformants could be obtained from either of the P. rettgeri isolates. NDM plasmids were shown additionally to harbour genes encoding resistance to several different classes of antibiotics (Table 2) .
Plasmid sequences exhibiting .99% similarity to pKP1-NDM-1 were obtained from isolates submitted from two additional laboratories between 2009 and 2014, and were found in multiple E. coli, E. cloacae complex and K. pneumoniae STs, suggesting that the plasmid is highly transmissible and has persisted in (or has been repeatedly introduced into) the West Midlands region.
VIM (n " 7)
VIM-positive isolates all belonged to K. pneumoniae ST15 and were submitted by a single laboratory over a 6 week period. All seven isolates carried bla VIM-4 on the same non-typeable plasmid of 26 kb, which exhibited .80% identity to pNOR-2000 (NC_020452), a 21.9 kb plasmid harbouring bla VIM-2 found in Pseudomonas aeruginosa in France. 33 The cluster of seven VIMpositive K. pneumoniae ST15 isolates suggests that these were a result of an outbreak and, aside from these, VIM-positive CPE did not appear to be prevalent in the West Midlands region.
NDM ! OXA-48-like (n " 1) One K. pneumoniae ST11 isolate co-produced NDM-1 and OXA-48. Plasmid analysis revealed that the bla NDM-1 gene was encoded on a non-typeable plasmid, whereas the bla OXA-48 gene was encoded on a plasmid with .99% identity to pOXA-48a.
Antibiotic susceptibility
Susceptibility testing was performed on all 139 isolates and MIC distributions are shown in Table 3 .
KPC producers
All 31 KPC-positive isolates were resistant or non-susceptible to all three carbapenems (ertapenem, imipenem and meropenem) tested. Colistin resistance was observed in one isolate with an MIC of 32 mg/L. Susceptibility to amikacin, gentamicin and tobramycin was observed in 81%, 90% and 77% of isolates, respectively. Tigecycline resistance was observed in one isolate with an MIC of 8 mg/L, whilst 35% (11/31) of isolates exhibited resistance to ciprofloxacin.
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OXA-48-like producers
All 21 OXA-48-like-positive isolates were resistant to ertapenem, whereas susceptibility to imipenem and meropenem was observed for 38% and 33% of isolates, respectively. All isolates remained susceptible to colistin. Seventy-four percent (14/19) of isolates tested were resistant to ciprofloxacin and 60% were nonsusceptible to tigecycline. Sixty-two percent, 67% and 75% of tested isolates were non-susceptible to amikacin, gentamicin and tobramycin, respectively. All isolates were non-susceptible to the third-generation cephalosporins ceftazidime and cefotaxime (data not shown).
NDM producers
All NDM-positive isolates were resistant or non-susceptible to all three carbapenems tested. Most isolates exhibited resistance or non-susceptibility to the aminoglycosides, with just 13%, 10% and 3% of isolates remaining susceptible to amikacin, gentamicin and tobramycin, respectively. Almost all isolates (78/79) were resistant to ciprofloxacin, whereas most were susceptible to colistin (95%; 71/75). Tigecycline susceptibility was observed in 40% of isolates.
VIM producers
All seven VIM-positive isolates were resistant or non-susceptible to all three carbapenems tested. All isolates were susceptible to both colistin and tigecycline, whilst ciprofloxacin resistance was observed in all isolates. The isolates all remained susceptible to amikacin, whereas only one isolate was susceptible to gentamicin and seven were resistant to tobramycin.
NDM and OXA-48-like producer
The single NDM and OXA-48-like-positive isolate was resistant to all antibiotics tested with the exceptions of colistin and tigecycline, to which it remained susceptible. Across all isolates, regardless of which carbapenemase(s) they yielded, colistin was the most active antimicrobial with 96% (129/134) of isolates remaining susceptible, followed by tigecycline with 53% susceptibility (73/137). Infection with CPE has been associated with extended hospital stays and increased mortality rates 9 and, in conjunction with their tendency to be MDR, has resulted in a situation where therapeutic options are severely limited. Colistin, tigecycline and fosfomycin are reported to be the most effective antimicrobials against CPE; 9 however, their indications and spectra of activity can vary greatly and consequently they can have somewhat limited use when used on their own. This has led in recent years to therapies where antibiotics of different classes are used in combination becoming more commonplace when dealing with CPE infections.
Conclusions
Increasing numbers of carbapenemases were evident over the entire study period (Figure 1 ) particularly bla NDM , bla KPC and bla OXA-48-like genes, indicative of increased prevalence, but this could be in part attributed to increased awareness and surveillance of carbapenemase-producing isolates in the medical setting. 34 The carbapenemase genes in this study were most often coresident with other resistance determinants, and plasmids form essential vehicles for their dissemination and possibly even their subsequent integration into the chromosome, as was observed with three bla OXA-48-like isolates. The observation of the same plasmids in different species and STs mean that non-clonal outbreaks Figure 1 . Numbers of carbapenemase-positive isolates, affected patients and sending laboratories, per year, during the study period. *One NDM-positive isolate was obtained from an endoscopic camera head.
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within a hospital or region could be missed as traditional strain typing methodologies do not address spread of the plasmids by themselves. With many institutions increasingly using WGS, it may in future become easier to identify polyclonal and multi-species outbreaks that are associated with plasmid promiscuity. Whilst this can be done relatively cheaply using short-read WGS (e.g. Illumina) data, it would require the construction of a localized plasmid reference database. Short-read WGS data alone are not ideal for de novo plasmid sequencing, but when combined with long-read technologies (e.g. PacBio and MinION) can offer a way to obtain plasmid outbreak data, after which the mapping of short read data may be adequate to track a plasmid outbreak for epidemiological purposes. Nevertheless, despite technological advances to aid detection, identifying realistic intervention measures that could prevent plasmid spread in healthcare settings will continue to be challenging.
